Nuciferine attenuates atherosclerosis by regulating the proliferation and migration of VSMCs through the Calm4/MMP12/AKT pathway in ApoE(-/-) mice fed with High-Fat-Diet

Atherosclerosis (AS) is the pathological basis of multiple cardiovascular diseases. The pathogenesis of AS is closely related to the abnormal proliferation and migration of vascular smooth muscle cells (VSMCs). Nuciferine, an aporphine alkaloid from lotus leaf, has various pharmacological activities...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Phytomedicine (Stuttgart) 2023-01, Vol.108, p.154536-154536, Article 154536
Hauptverfasser: Xiao, Mingzhu, Xian, Cuiling, Wang, Ying, Qi, Xiaoxiao, Zhang, Rong, Liu, Zhongqiu, Cheng, Yuanyuan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 154536
container_issue
container_start_page 154536
container_title Phytomedicine (Stuttgart)
container_volume 108
creator Xiao, Mingzhu
Xian, Cuiling
Wang, Ying
Qi, Xiaoxiao
Zhang, Rong
Liu, Zhongqiu
Cheng, Yuanyuan
description Atherosclerosis (AS) is the pathological basis of multiple cardiovascular diseases. The pathogenesis of AS is closely related to the abnormal proliferation and migration of vascular smooth muscle cells (VSMCs). Nuciferine, an aporphine alkaloid from lotus leaf, has various pharmacological activities. However, the effect and mechanism of nuciferine on regulating proliferation and migration of VSMCs against AS is still unclear. To elucidate the pharmacological effect and molecular mechanism of nuciferine on AS in ApoE(-/-) mice fed with High-Fat-Diet (HFD). HFD-fed ApoE(-/-) mice and 3% fetal bovine serum (FBS) induced mouse aortic vascular smooth muscle cells (MOVAS) were used to investigate the protective effect and mechanism of nuciferine on AS. Oil red O staining was used to detect the atherosclerotic lesions. Western blotting and immunofluorescence were used to determine calmodulin 4 (Calm4) expression and localization. CCK-8 assay, transwell and wound-healing assays were used to measure the migration and proliferation of MOVAS cells. Nuciferine at 40 mg/kg significantly ameliorated the aortic lesion and vascular plaque in AS model, which was equal to the effect of the positive control drug (atorvastatin). In addition, nuciferine attenuated the migration and proliferation of VSMCs in vivo and in vitro. Importantly, nuciferine down-regulated the increase of Calm4 induced by HFD-fed in ApoE(-/-) mice or 3% FBS induced MOVAS cells. However, the inhibitory effect of nuciferine on the migration and proliferation of MOVAS cells was blocked when Calm4 was overexpressed. Furthermore, we found that nuciferine suppressed MMP12 and PI3K/Akt signaling pathway via Calm4. Our results illustrated that Calm4 promoted the proliferation and motility of MOVAS by activating MMP12/Akt signaling pathway in AS. Nuciferine has a significant anti-atherogenic effect by regulating the proliferation and migration of VSMCs through the Calm4/MMP12/AKT signaling pathway. Thus, Calm4 could potentially be a new target for AS therapy, and nuciferine could be a potential drug against AS. [Display omitted]
doi_str_mv 10.1016/j.phymed.2022.154536
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3153848405</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0944711322006249</els_id><sourcerecordid>3153848405</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-ca6d0968d8368a770504c7d4169d8c82848a00a0779d212c630a16765ae358423</originalsourceid><addsrcrecordid>eNqFUU2P0zAQjRBIlIV_wMHH5ZDWX7GdC1JVdlnEFpBYEDfL2JPEVT66tsOqP4l_iUv2DBePZ-a9N5p5RfGa4DXBRGwO62N3GsCtKaZ0TSpeMfGkWBFBVInr6sfTYoVrzktJCHtevIjxgDHhtcSr4ven2foGgh8BmZRgnE2CmL8dhCna_vz6iH6eUIB27k3yY4tyEx3D1J-JuTKNyIwODb59zKYGff-638UMDNPcdn8JO9MPfLPffyF0s_14h455xoM5IT-i7XG6uiw35ZusYQE14NCDTx268W1XXptUvvOQXhbPGtNHePUYL4pv11d3u5vy9vP7D7vtbWmZpKm0RjhcC-UUE8pIiSvMrXSciNopq6jiymBssJS1o4RawbAhQorKAKsUp-yiuFx084b3M8SkBx8t9L0ZYZqjZqRiWYTj6r9QKpkiNak5yVC-QG0-aAzQ6GPwgwknTbA-m6gPejFRn03Ui4mZ9nahQd74l4ego_UwWnA-gE3aTf7fAn8AxJqmVA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2738191941</pqid></control><display><type>article</type><title>Nuciferine attenuates atherosclerosis by regulating the proliferation and migration of VSMCs through the Calm4/MMP12/AKT pathway in ApoE(-/-) mice fed with High-Fat-Diet</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Xiao, Mingzhu ; Xian, Cuiling ; Wang, Ying ; Qi, Xiaoxiao ; Zhang, Rong ; Liu, Zhongqiu ; Cheng, Yuanyuan</creator><creatorcontrib>Xiao, Mingzhu ; Xian, Cuiling ; Wang, Ying ; Qi, Xiaoxiao ; Zhang, Rong ; Liu, Zhongqiu ; Cheng, Yuanyuan</creatorcontrib><description>Atherosclerosis (AS) is the pathological basis of multiple cardiovascular diseases. The pathogenesis of AS is closely related to the abnormal proliferation and migration of vascular smooth muscle cells (VSMCs). Nuciferine, an aporphine alkaloid from lotus leaf, has various pharmacological activities. However, the effect and mechanism of nuciferine on regulating proliferation and migration of VSMCs against AS is still unclear. To elucidate the pharmacological effect and molecular mechanism of nuciferine on AS in ApoE(-/-) mice fed with High-Fat-Diet (HFD). HFD-fed ApoE(-/-) mice and 3% fetal bovine serum (FBS) induced mouse aortic vascular smooth muscle cells (MOVAS) were used to investigate the protective effect and mechanism of nuciferine on AS. Oil red O staining was used to detect the atherosclerotic lesions. Western blotting and immunofluorescence were used to determine calmodulin 4 (Calm4) expression and localization. CCK-8 assay, transwell and wound-healing assays were used to measure the migration and proliferation of MOVAS cells. Nuciferine at 40 mg/kg significantly ameliorated the aortic lesion and vascular plaque in AS model, which was equal to the effect of the positive control drug (atorvastatin). In addition, nuciferine attenuated the migration and proliferation of VSMCs in vivo and in vitro. Importantly, nuciferine down-regulated the increase of Calm4 induced by HFD-fed in ApoE(-/-) mice or 3% FBS induced MOVAS cells. However, the inhibitory effect of nuciferine on the migration and proliferation of MOVAS cells was blocked when Calm4 was overexpressed. Furthermore, we found that nuciferine suppressed MMP12 and PI3K/Akt signaling pathway via Calm4. Our results illustrated that Calm4 promoted the proliferation and motility of MOVAS by activating MMP12/Akt signaling pathway in AS. Nuciferine has a significant anti-atherogenic effect by regulating the proliferation and migration of VSMCs through the Calm4/MMP12/AKT signaling pathway. Thus, Calm4 could potentially be a new target for AS therapy, and nuciferine could be a potential drug against AS. [Display omitted]</description><identifier>ISSN: 0944-7113</identifier><identifier>EISSN: 1618-095X</identifier><identifier>DOI: 10.1016/j.phymed.2022.154536</identifier><language>eng</language><publisher>Elsevier GmbH</publisher><subject>alkaloids ; Atherosclerosis ; atorvastatin ; Calm4 ; calmodulin ; drugs ; fetal bovine serum ; fluorescent antibody technique ; high fat diet ; leaves ; mice ; MMP12 ; Nuciferine ; pathogenesis ; PI3K-AKT pathway ; protective effect ; smooth muscle ; therapeutics ; Vascular smooth muscle cells</subject><ispartof>Phytomedicine (Stuttgart), 2023-01, Vol.108, p.154536-154536, Article 154536</ispartof><rights>2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-ca6d0968d8368a770504c7d4169d8c82848a00a0779d212c630a16765ae358423</citedby><cites>FETCH-LOGICAL-c372t-ca6d0968d8368a770504c7d4169d8c82848a00a0779d212c630a16765ae358423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0944711322006249$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids></links><search><creatorcontrib>Xiao, Mingzhu</creatorcontrib><creatorcontrib>Xian, Cuiling</creatorcontrib><creatorcontrib>Wang, Ying</creatorcontrib><creatorcontrib>Qi, Xiaoxiao</creatorcontrib><creatorcontrib>Zhang, Rong</creatorcontrib><creatorcontrib>Liu, Zhongqiu</creatorcontrib><creatorcontrib>Cheng, Yuanyuan</creatorcontrib><title>Nuciferine attenuates atherosclerosis by regulating the proliferation and migration of VSMCs through the Calm4/MMP12/AKT pathway in ApoE(-/-) mice fed with High-Fat-Diet</title><title>Phytomedicine (Stuttgart)</title><description>Atherosclerosis (AS) is the pathological basis of multiple cardiovascular diseases. The pathogenesis of AS is closely related to the abnormal proliferation and migration of vascular smooth muscle cells (VSMCs). Nuciferine, an aporphine alkaloid from lotus leaf, has various pharmacological activities. However, the effect and mechanism of nuciferine on regulating proliferation and migration of VSMCs against AS is still unclear. To elucidate the pharmacological effect and molecular mechanism of nuciferine on AS in ApoE(-/-) mice fed with High-Fat-Diet (HFD). HFD-fed ApoE(-/-) mice and 3% fetal bovine serum (FBS) induced mouse aortic vascular smooth muscle cells (MOVAS) were used to investigate the protective effect and mechanism of nuciferine on AS. Oil red O staining was used to detect the atherosclerotic lesions. Western blotting and immunofluorescence were used to determine calmodulin 4 (Calm4) expression and localization. CCK-8 assay, transwell and wound-healing assays were used to measure the migration and proliferation of MOVAS cells. Nuciferine at 40 mg/kg significantly ameliorated the aortic lesion and vascular plaque in AS model, which was equal to the effect of the positive control drug (atorvastatin). In addition, nuciferine attenuated the migration and proliferation of VSMCs in vivo and in vitro. Importantly, nuciferine down-regulated the increase of Calm4 induced by HFD-fed in ApoE(-/-) mice or 3% FBS induced MOVAS cells. However, the inhibitory effect of nuciferine on the migration and proliferation of MOVAS cells was blocked when Calm4 was overexpressed. Furthermore, we found that nuciferine suppressed MMP12 and PI3K/Akt signaling pathway via Calm4. Our results illustrated that Calm4 promoted the proliferation and motility of MOVAS by activating MMP12/Akt signaling pathway in AS. Nuciferine has a significant anti-atherogenic effect by regulating the proliferation and migration of VSMCs through the Calm4/MMP12/AKT signaling pathway. Thus, Calm4 could potentially be a new target for AS therapy, and nuciferine could be a potential drug against AS. [Display omitted]</description><subject>alkaloids</subject><subject>Atherosclerosis</subject><subject>atorvastatin</subject><subject>Calm4</subject><subject>calmodulin</subject><subject>drugs</subject><subject>fetal bovine serum</subject><subject>fluorescent antibody technique</subject><subject>high fat diet</subject><subject>leaves</subject><subject>mice</subject><subject>MMP12</subject><subject>Nuciferine</subject><subject>pathogenesis</subject><subject>PI3K-AKT pathway</subject><subject>protective effect</subject><subject>smooth muscle</subject><subject>therapeutics</subject><subject>Vascular smooth muscle cells</subject><issn>0944-7113</issn><issn>1618-095X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqFUU2P0zAQjRBIlIV_wMHH5ZDWX7GdC1JVdlnEFpBYEDfL2JPEVT66tsOqP4l_iUv2DBePZ-a9N5p5RfGa4DXBRGwO62N3GsCtKaZ0TSpeMfGkWBFBVInr6sfTYoVrzktJCHtevIjxgDHhtcSr4ven2foGgh8BmZRgnE2CmL8dhCna_vz6iH6eUIB27k3yY4tyEx3D1J-JuTKNyIwODb59zKYGff-638UMDNPcdn8JO9MPfLPffyF0s_14h455xoM5IT-i7XG6uiw35ZusYQE14NCDTx268W1XXptUvvOQXhbPGtNHePUYL4pv11d3u5vy9vP7D7vtbWmZpKm0RjhcC-UUE8pIiSvMrXSciNopq6jiymBssJS1o4RawbAhQorKAKsUp-yiuFx084b3M8SkBx8t9L0ZYZqjZqRiWYTj6r9QKpkiNak5yVC-QG0-aAzQ6GPwgwknTbA-m6gPejFRn03Ui4mZ9nahQd74l4ego_UwWnA-gE3aTf7fAn8AxJqmVA</recordid><startdate>202301</startdate><enddate>202301</enddate><creator>Xiao, Mingzhu</creator><creator>Xian, Cuiling</creator><creator>Wang, Ying</creator><creator>Qi, Xiaoxiao</creator><creator>Zhang, Rong</creator><creator>Liu, Zhongqiu</creator><creator>Cheng, Yuanyuan</creator><general>Elsevier GmbH</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope></search><sort><creationdate>202301</creationdate><title>Nuciferine attenuates atherosclerosis by regulating the proliferation and migration of VSMCs through the Calm4/MMP12/AKT pathway in ApoE(-/-) mice fed with High-Fat-Diet</title><author>Xiao, Mingzhu ; Xian, Cuiling ; Wang, Ying ; Qi, Xiaoxiao ; Zhang, Rong ; Liu, Zhongqiu ; Cheng, Yuanyuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-ca6d0968d8368a770504c7d4169d8c82848a00a0779d212c630a16765ae358423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>alkaloids</topic><topic>Atherosclerosis</topic><topic>atorvastatin</topic><topic>Calm4</topic><topic>calmodulin</topic><topic>drugs</topic><topic>fetal bovine serum</topic><topic>fluorescent antibody technique</topic><topic>high fat diet</topic><topic>leaves</topic><topic>mice</topic><topic>MMP12</topic><topic>Nuciferine</topic><topic>pathogenesis</topic><topic>PI3K-AKT pathway</topic><topic>protective effect</topic><topic>smooth muscle</topic><topic>therapeutics</topic><topic>Vascular smooth muscle cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xiao, Mingzhu</creatorcontrib><creatorcontrib>Xian, Cuiling</creatorcontrib><creatorcontrib>Wang, Ying</creatorcontrib><creatorcontrib>Qi, Xiaoxiao</creatorcontrib><creatorcontrib>Zhang, Rong</creatorcontrib><creatorcontrib>Liu, Zhongqiu</creatorcontrib><creatorcontrib>Cheng, Yuanyuan</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>Phytomedicine (Stuttgart)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xiao, Mingzhu</au><au>Xian, Cuiling</au><au>Wang, Ying</au><au>Qi, Xiaoxiao</au><au>Zhang, Rong</au><au>Liu, Zhongqiu</au><au>Cheng, Yuanyuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nuciferine attenuates atherosclerosis by regulating the proliferation and migration of VSMCs through the Calm4/MMP12/AKT pathway in ApoE(-/-) mice fed with High-Fat-Diet</atitle><jtitle>Phytomedicine (Stuttgart)</jtitle><date>2023-01</date><risdate>2023</risdate><volume>108</volume><spage>154536</spage><epage>154536</epage><pages>154536-154536</pages><artnum>154536</artnum><issn>0944-7113</issn><eissn>1618-095X</eissn><abstract>Atherosclerosis (AS) is the pathological basis of multiple cardiovascular diseases. The pathogenesis of AS is closely related to the abnormal proliferation and migration of vascular smooth muscle cells (VSMCs). Nuciferine, an aporphine alkaloid from lotus leaf, has various pharmacological activities. However, the effect and mechanism of nuciferine on regulating proliferation and migration of VSMCs against AS is still unclear. To elucidate the pharmacological effect and molecular mechanism of nuciferine on AS in ApoE(-/-) mice fed with High-Fat-Diet (HFD). HFD-fed ApoE(-/-) mice and 3% fetal bovine serum (FBS) induced mouse aortic vascular smooth muscle cells (MOVAS) were used to investigate the protective effect and mechanism of nuciferine on AS. Oil red O staining was used to detect the atherosclerotic lesions. Western blotting and immunofluorescence were used to determine calmodulin 4 (Calm4) expression and localization. CCK-8 assay, transwell and wound-healing assays were used to measure the migration and proliferation of MOVAS cells. Nuciferine at 40 mg/kg significantly ameliorated the aortic lesion and vascular plaque in AS model, which was equal to the effect of the positive control drug (atorvastatin). In addition, nuciferine attenuated the migration and proliferation of VSMCs in vivo and in vitro. Importantly, nuciferine down-regulated the increase of Calm4 induced by HFD-fed in ApoE(-/-) mice or 3% FBS induced MOVAS cells. However, the inhibitory effect of nuciferine on the migration and proliferation of MOVAS cells was blocked when Calm4 was overexpressed. Furthermore, we found that nuciferine suppressed MMP12 and PI3K/Akt signaling pathway via Calm4. Our results illustrated that Calm4 promoted the proliferation and motility of MOVAS by activating MMP12/Akt signaling pathway in AS. Nuciferine has a significant anti-atherogenic effect by regulating the proliferation and migration of VSMCs through the Calm4/MMP12/AKT signaling pathway. Thus, Calm4 could potentially be a new target for AS therapy, and nuciferine could be a potential drug against AS. [Display omitted]</abstract><pub>Elsevier GmbH</pub><doi>10.1016/j.phymed.2022.154536</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0944-7113
ispartof Phytomedicine (Stuttgart), 2023-01, Vol.108, p.154536-154536, Article 154536
issn 0944-7113
1618-095X
language eng
recordid cdi_proquest_miscellaneous_3153848405
source Elsevier ScienceDirect Journals Complete
subjects alkaloids
Atherosclerosis
atorvastatin
Calm4
calmodulin
drugs
fetal bovine serum
fluorescent antibody technique
high fat diet
leaves
mice
MMP12
Nuciferine
pathogenesis
PI3K-AKT pathway
protective effect
smooth muscle
therapeutics
Vascular smooth muscle cells
title Nuciferine attenuates atherosclerosis by regulating the proliferation and migration of VSMCs through the Calm4/MMP12/AKT pathway in ApoE(-/-) mice fed with High-Fat-Diet
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T09%3A26%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nuciferine%20attenuates%20atherosclerosis%20by%20regulating%20the%20proliferation%20and%20migration%20of%20VSMCs%20through%20the%20Calm4/MMP12/AKT%20pathway%20in%20ApoE(-/-)%20mice%20fed%20with%20High-Fat-Diet&rft.jtitle=Phytomedicine%20(Stuttgart)&rft.au=Xiao,%20Mingzhu&rft.date=2023-01&rft.volume=108&rft.spage=154536&rft.epage=154536&rft.pages=154536-154536&rft.artnum=154536&rft.issn=0944-7113&rft.eissn=1618-095X&rft_id=info:doi/10.1016/j.phymed.2022.154536&rft_dat=%3Cproquest_cross%3E3153848405%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2738191941&rft_id=info:pmid/&rft_els_id=S0944711322006249&rfr_iscdi=true